Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

Cited In for PubMed (Select 16936720)

1.

Expression of executioner procaspases and their activation by a procaspase-activating compound in chronic lymphocytic leukemia cells.

Patel V, Balakrishnan K, Keating MJ, Wierda WG, Gandhi V.

Blood. 2015 Feb 12;125(7):1126-36. doi: 10.1182/blood-2014-01-546796. Epub 2014 Dec 23.

PMID:
25538042
2.

Molecular mechanisms of leptin and pro-apoptotic signals induced by menadione in HepG2 cells.

Al-Suhaimi E.

Saudi J Biol Sci. 2014 Dec;21(6):582-8. doi: 10.1016/j.sjbs.2014.03.002. Epub 2014 Mar 31.

3.

Turning on caspases with genetics and small molecules.

Morgan CW, Julien O, Unger EK, Shah NM, Wells JA.

Methods Enzymol. 2014;544:179-213. doi: 10.1016/B978-0-12-417158-9.00008-X. Review.

4.

The role of mitochondria in the development and progression of lung cancer.

Roberts ER, Thomas KJ.

Comput Struct Biotechnol J. 2013 Dec 7;6:e201303019. doi: 10.5936/csbj.201303019. eCollection 2013. Review.

5.

Local caspase activation interacts with Slit-Robo signaling to restrict axonal arborization.

Campbell DS, Okamoto H.

J Cell Biol. 2013 Nov 25;203(4):657-72. doi: 10.1083/jcb.201303072.

6.

Dual small-molecule targeting of procaspase-3 dramatically enhances zymogen activation and anticancer activity.

Botham RC, Fan TM, Im I, Borst LB, Dirikolu L, Hergenrother PJ.

J Am Chem Soc. 2014 Jan 29;136(4):1312-9. doi: 10.1021/ja4124303. Epub 2014 Jan 16.

7.

ERO1α-dependent endoplasmic reticulum-mitochondrial calcium flux contributes to ER stress and mitochondrial permeabilization by procaspase-activating compound-1 (PAC-1).

Seervi M, Sobhan PK, Joseph J, Ann Mathew K, Santhoshkumar TR.

Cell Death Dis. 2013 Dec 19;4:e968. doi: 10.1038/cddis.2013.502.

8.

Targeting the apoptosis pathway in hematologic malignancies.

Zaman S, Wang R, Gandhi V.

Leuk Lymphoma. 2014 Sep;55(9):1980-92. doi: 10.3109/10428194.2013.855307. Epub 2014 Feb 4. Review.

9.

Suicide Gene Therapy for Cancer - Current Strategies.

Zarogoulidis P, Darwiche K, Sakkas A, Yarmus L, Huang H, Li Q, Freitag L, Zarogoulidis K, Malecki M.

J Genet Syndr Gene Ther. 2013 Aug 9;4. pii: 16849.

10.

Intrinsic-mediated caspase activation is essential for cardiomyocyte hypertrophy.

Putinski C, Abdul-Ghani M, Stiles R, Brunette S, Dick SA, Fernando P, Megeney LA.

Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):E4079-87. doi: 10.1073/pnas.1315587110. Epub 2013 Oct 7.

11.

Specificity of a protein-protein interface: local dynamics direct substrate recognition of effector caspases.

Fuchs JE, von Grafenstein S, Huber RG, Wallnoefer HG, Liedl KR.

Proteins. 2014 Apr;82(4):546-55. doi: 10.1002/prot.24417. Epub 2013 Oct 19. Erratum in: Proteins. 2014 Oct;82(10):2887.

12.

A novel reporter system for molecular imaging and high-throughput screening of anticancer drugs.

Xie J, Wang C, Virostko J, Manning HC, Pham W, Bauer J, Gore JC.

Chembiochem. 2013 Aug 19;14(12):1494-503. doi: 10.1002/cbic.201300142. Epub 2013 Jul 24.

13.

Structural snapshots reveal distinct mechanisms of procaspase-3 and -7 activation.

Thomsen ND, Koerber JT, Wells JA.

Proc Natl Acad Sci U S A. 2013 May 21;110(21):8477-82. doi: 10.1073/pnas.1306759110. Epub 2013 May 6.

14.

Caspase functions in cell death and disease.

McIlwain DR, Berger T, Mak TW.

Cold Spring Harb Perspect Biol. 2013 Apr 1;5(4):a008656. doi: 10.1101/cshperspect.a008656. Review.

15.

Fibrils colocalize caspase-3 with procaspase-3 to foster maturation.

Zorn JA, Wolan DW, Agard NJ, Wells JA.

J Biol Chem. 2012 Sep 28;287(40):33781-95. Epub 2012 Aug 7.

16.

Schiff bases of indoline-2,3-dione (isatin) with potential antiproliferative activity.

Aboul-Fadl T, Radwan AA, Attia MI, Al-Dhfyan A, Abdel-Aziz HA.

Chem Cent J. 2012 May 30;6(1):49. doi: 10.1186/1752-153X-6-49.

17.

Differential effects of procaspase-3 activating compounds in the induction of cancer cell death.

West DC, Qin Y, Peterson QP, Thomas DL, Palchaudhuri R, Morrison KC, Lucas PW, Palmer AE, Fan TM, Hergenrother PJ.

Mol Pharm. 2012 May 7;9(5):1425-34. doi: 10.1021/mp200673n. Epub 2012 Apr 27.

18.

Apoptosome-dependent caspase activation proteins as prognostic markers in Stage II and III colorectal cancer.

Hector S, Conlon S, Schmid J, Dicker P, Cummins RJ, Concannon CG, Johnston PG, Kay EW, Prehn JH.

Br J Cancer. 2012 Apr 24;106(9):1499-1505. doi: 10.1038/bjc.2012.133.

19.

Parallel synthesis and biological evaluation of 837 analogues of procaspase-activating compound 1 (PAC-1).

Hsu DC, Roth HS, West DC, Botham RC, Novotny CJ, Schmid SC, Hergenrother PJ.

ACS Comb Sci. 2012 Jan 9;14(1):44-50. doi: 10.1021/co2001372. Epub 2011 Oct 28.

20.

Essential requirement of cytochrome c release for caspase activation by procaspase-activating compound defined by cellular models.

Seervi M, Joseph J, Sobhan PK, Bhavya BC, Santhoshkumar TR.

Cell Death Dis. 2011 Sep 8;2:e207. doi: 10.1038/cddis.2011.90.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk